Research output per year
Research output per year
- 50 - 60 out of 60 results
Search results
-
2011
Effect of omeprazole on the pharmacokinetics and toxicities of irinotecan in cancer patients: a prospective cross-over drug-drug interaction study
Bol, J., Loos, W., de Jong, F., van Meerten, E., Konings, I., Lam, M., de Bruijn, P., Wiemer, E., Verweij, J. & Mathijssen, R., Apr 2011, In: European Journal of Cancer. 47, 6, p. 831-838 8 p.Research output: Contribution to journal › Article › Academic › peer-review
17 Citations (Scopus) -
2009
Pathological Analysis After Neoadjuvant Chemoradiotherapy for Esophageal Carcinoma: The Rotterdam Experience
van Meerten, E., van der Gaast, A., Tilanus, H., Poley, J.-W., Muller, K. & van Dekken, H., 2009, In: Journal of Surgical Oncology. 100, 1, p. 32-37 6 p.Research output: Contribution to journal › Article › Academic › peer-review
21 Citations (Scopus) -
2008
Chemotherapy and chemoradiotherapy studies in oesophageal cancer
van Meerten, E., 12 Sept 2008, Erasmus Universiteit Rotterdam (EUR).Research output: Types of Thesis › Doctoral Thesis › Internal
Open AccessFile8 Downloads (Pure) -
Chemotherapie bij gebruik van clozapine; een verhoogde kans op agranulocytose?
Gool, A., van der Velden, M., Oosten, A., van Meerten, E., Verhoeven, W. & Loonen, A., 2008, In: Tijdschrift voor Psychiatrie. 50, 10, p. 673-678 6 p.Research output: Contribution to journal › Article › Professional › peer-review
2 Citations (Scopus) -
Quality of life during neoadjuvant treatment and after surgery for resectable esophageal carcinoma
van Meerten, E., van der Gaast, A., Looman, C., Tilanus, H., Muller, K. & Bot, M.-L., 2008, In: International Journal of Radiation Oncology Biology Physics. 71, 1, p. 160-166 7 p.Research output: Contribution to journal › Article › Academic › peer-review
46 Citations (Scopus) -
2007
First-line treatment with oxaliplatin and capecitabine in patients with advanced or metastatic oesophageal cancer: a phase II study
van Meerten, E., Eskens, F., van Gameren, E., van Doorn, L. & van der Gaast, A., 2007, In: British Journal of Cancer. 96, 9, p. 1348-1352 5 p.Research output: Contribution to journal › Article › Academic › peer-review
38 Citations (Scopus) -
2006
Neoadjuvant concurrent chemoradiation with weekly paclitaxel and carboplatin for patients with oesophageal cancer: a phase II study
van Meerten, E., Muller, K., Tilanus, H., Siersema, P., Eijkenboom, W., van Dekken, H., Tran, K. & van der Gaast, A., 2006, In: British Journal of Cancer. 94, 10, p. 1389-1394 6 p.Research output: Contribution to journal › Article › Academic › peer-review
109 Citations (Scopus) -
2005
Systemic treatment for oesophageal cancer
van Meerten, E. & van der Gaast, A., 2005, In: European Journal of Cancer. 41, 5, p. 664-672 9 p.Research output: Contribution to journal › Article › Academic › peer-review
31 Citations (Scopus) -
1996
Relationship between the exposure to cisplatin, DNA-adduct formation in leucocytes and tumour response in patients with solid tumours
Schellens, J. H. M., Ma, J., Planting, A. S. T., Van Der Burg, M. E. L., Van Meerten, E., De Boer-Dennert, M., Schmitz, P. I. M., Stoter, G. & Verweij, J., 1 Jun 1996, In: British Journal of Cancer. 73, 12, p. 1569-1575 7 p.Research output: Contribution to journal › Article › Academic › peer-review
137 Citations (Scopus) -
1995
Antineoplastic Agents: Drug Interactions of Clinical Significance
van Meerten, E., Verweij, J. & Schellens, J. H. M., Mar 1995, In: Drug Safety. 12, 3, p. 168-182 15 p.Research output: Contribution to journal › Review article › Academic › peer-review
35 Citations (Scopus)